위암의 한방치료 활성화를 위한 한방의료정책 보완에 관한 제안
Proposal on Spplementation to Oriental Medical Policy for the Revitalization of Oriental Medical Therapy for Stomach Cancer
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Gastric cancer is common cancer generating about 20% incidence in Korea. But Oriental medical doctor (OMD) often can't measure therapy on gastric cancer positively because that the prognosis on it is not good. It is impossible the results on all of diseases not only gastric cancer always to have to be good. It is required to find out the causes of diseases and therapy method to conquest the diseases for the medical therapy. But because the results on medical therapy are not always good, it is necessary for the doctor who want to treat the diseases like gastric cancer having the prognosis to be death to protect himself, like as the legal system, a medical policy. And consequently, this protecting legal system lead the medical therapy principle or method on some special diseases to therapy completion on it. As a results of policy, medical therapy have to be developed. It is studied the literature referencing gastric cancer, experimental articles to insist the effects of Oriental medicine planet to gastric cancer and the clinical cases on gastric cancer to be treated as Oriental medicine therapy to have effects. Recently, there have been many other development in oriental medical therapy. This development can be grouped as two type. One type is clinical part and the other is experimental research part. Specially the experimental research and clinical research on gastric cancer in oriental medical therapy have been developed. So the present day is the time to make medical policy on liver cancer for OMD to measure oriental medical therapy and develop oriental medical theory. As a above results, we propose that the name of gastric cancer have to use in Korean medicine security clinical name (한방의료보험상병명) to make oriental medical policy.
Abstract
Gastric cancer is common cancer generating about 20% incidence in Korea. But Oriental medical doctor (OMD) often can't measure therapy on gastric cancer positively because that the prognosis on it is not good. It is impossible the results on all of diseases not only gastric cancer always to have to be good. It is required to find out the causes of diseases and therapy method to conquest the diseases for the medical therapy. But because the results on medical therapy are not always good, it is necessary for the doctor who want to treat the diseases like gastric cancer having the prognosis to be death to protect himself, like as the legal system, a medical policy. And consequently, this protecting legal system lead the medical therapy principle or method on some special diseases to therapy completion on it. As a results of policy, medical therapy have to be developed. It is studied the literature referencing gastric cancer, experimental articles to insist the effects of Oriental medicine planet to gastric cancer and the clinical cases on gastric cancer to be treated as Oriental medicine therapy to have effects. Recently, there have been many other development in oriental medical therapy. This development can be grouped as two type. One type is clinical part and the other is experimental research part. Specially the experimental research and clinical research on gastric cancer in oriental medical therapy have been developed. So the present day is the time to make medical policy on liver cancer for OMD to measure oriental medical therapy and develop oriental medical theory. As a above results, we propose that the name of gastric cancer have to use in Korean medicine security clinical name (한방의료보험상병명) to make oriental medical policy.
참고문헌 (23)
- 국립암센타, "암정보", pp.109~114 (2004), 국립암센타
- Kim, I.S, "Current status and change of 5 most common causes of death in Korea", J Korean Medical Assoc, 22, pp.132~145 (1995)
- 최승훈, "동의종양학 1판", pp.178~188 (1995), 영림출판사
- 조종관, "한방임상종양학 2판", pp.3~4 (2005), 주민출판사
- 이가경, "中醫腫瘍防治大全", pp.323~328, 과학기술문헌출판사
- 상민의, "實用抗癌驗方", pp.157~186, 중국의학기술출판사
- 신천호, "癌瘍防治硏究", pp.65~75 (1984), 신광문화사
- 주국평, "癌症秘方驗方偏方大全", pp.168~206, 의학기술출판사
- 진의문, "中西醫結合腫瘤防治手冊", pp.97~105 (1980), 신화출판사
- 홍원식, "現代中共의 癌治療", pp.166~173, 영문사
- 상민의, "註解解說抗癌本草", pp.489~492 (1992), 바람과물결
- 윤길영, "東醫臨床方劑學", pp.451~452 (1989), 명보출판사
- 유운, "암은 진맥과 침 뜸으로 치료된다. 초판", pp.206~208 (2002), 의성당
- 조종관, "한의학의 암치료기술 처방집. 초판", pp.11~42 (2008), 의성당
- 이재준, "지금초 추출물에 의한 TRAIL 저항성 인체위암세포의 세포사멸 유도", 생명과학회지, 18(1), pp.120~128 (2008), 한국생명과학회
- 최창본, "호박분말이 Sprague-Dawley 흰쥐에서 인위적으로 유발한 위암 및 유선암에 미치는 영향", 한국식품영양과학회지, 27(5), pp.973~979 (1998)
- 이인선, "복분자 추출물의 항산화활성 및 인간 위암 세포주에 대한 유전적 손상 유도", 생명과학회지, 17(12), pp.1723~1728 (2007), 한국생명과학회
- 김호정, "감잎 에탄올 추출물이 위암, 간암 및 대장암 세포주에 미치는 항암효과", 박사
- 김창한, "Clonogenic Assay에 의한 홍삼 소수성단백질 분회의 항암효과", 고려인삼학회지, 19(1), pp.27~30 (1996)
- 박갑주, "한방처방제의 인체 위암 세포주에 대한 세포 독성 효과에 관한 연구", 생약학회지, 28(4), pp.233~238 (1997)
- 김진복, "위암 환자에서 수술후 인삼의 장기간 투여가 면역 기능 및 영양 상태에 미치는 영향", 대한외과학회지, 154(6), pp.854~862 (1998)
- 김진성, "수종 한약제의 위암세포에 대한 항암 작용 효능 검색 및 약리작용에 관한 분자생물학적 연구", J. of Kor. Oriental Oncology, 5(1), pp.47~60 (1999)
- 조종관, "한의학의 암치료기술. 초판", pp.90~91 (2006), 의성당